Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A condition characterized by a burning or tingling sensation on the lips, tongue, or entire mouth.
Biomarker and diagnostic research for burning mouth syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
7 clinical trials registered, 1 recruiting. Interventions under study include other interventions, medical devices, and drug therapy. Pipeline includes 1 PHASE4, 1 EARLY_PHASE1, 4 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06040190](https://clinicaltrials.gov/study/NCT06040190) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 12:07 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome |
PHASE4 |
Federal University of Minas Gerais |
UNKNOWN |
[NCT05819697](https://clinicaltrials.gov/study/NCT05819697) | Reducing Patient Memory Recall in the Burning Mouth Patient Population | — | University of Pennsylvania | UNKNOWN |
[NCT07381361](https://clinicaltrials.gov/study/NCT07381361) | Photobiomodulation Therapy vs. Alpha-Lipoic Acid in Burning Mouth Syndrome Treatment | NA | Lu Jiang | UNKNOWN |
[NCT07016555](https://clinicaltrials.gov/study/NCT07016555) | Burning Mouth Syndrome: Symptoms and Management | EARLY_PHASE1 | University of Massachusetts, Amherst | UNKNOWN |
[NCT07344909](https://clinicaltrials.gov/study/NCT07344909) | Burning Mouth Syndrome: Effects of Occlusal Splint Therapy | NA | Malmö University | UNKNOWN |
206 publications have been identified in PubMed for burning mouth syndrome. Kisho has analyzed 82 by research type. Research spans Review / Meta-Analysis (46%), Other (11%), and Clinical Trial Publication (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 38 | 46% |
Other research | 9 | 11% |
Clinical study results | 9 | 11% |
Disease patterns and progression | 9 | 11% |
Testing and diagnosis research | 6 | 7% |
Laboratory research | 6 | 7% |
Patient case studies | 5 | 6% |
Musella G (2026). [PMID: 42187028](https://pubmed.ncbi.nlm.nih.gov/42187028/). *Cephalalgia*. [Other]
Canfora F (2026). [PMID: 41607318](https://pubmed.ncbi.nlm.nih.gov/41607318/). *J Oral Facial Pain Headache*. [Review / Meta-Analysis]
Nagamine T (2026). [PMID: 41387090](https://pubmed.ncbi.nlm.nih.gov/41387090/). *J Oral Rehabil*. [Review / Meta-Analysis]
Khorshidi Asl Z (2026). [PMID: 41858644](https://pubmed.ncbi.nlm.nih.gov/41858644/). *Biomed Hub*. [Clinical Trial Publication]
Lu C (2026). [PMID: 41338367](https://pubmed.ncbi.nlm.nih.gov/41338367/). *J Dent*. [Clinical Trial Publication]
Lin J (2026). [PMID: 41123107](https://pubmed.ncbi.nlm.nih.gov/41123107/). *Oral Dis*. [Review / Meta-Analysis]
Alonso-Navarro H (2026). [PMID: 41243075](https://pubmed.ncbi.nlm.nih.gov/41243075/). *Acta Neurol Belg*. [Other]
El-Rubaiy M (2026). [PMID: 42244168](https://pubmed.ncbi.nlm.nih.gov/42244168/). *Cephalalgia*. [Diagnostic / Biomarker]
de Paiva JPG (2026). [PMID: 41240323](https://pubmed.ncbi.nlm.nih.gov/41240323/). *Oral Dis*. [Review / Meta-Analysis]
Yang G (2025). [PMID: 39496500](https://pubmed.ncbi.nlm.nih.gov/39496500/). *J Oral Rehabil*. [Clinical Trial Publication]